Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
17.44B | 17.22B | 17.09B | 18.59B | 17.66B | 17.73B | Gross Profit |
2.81B | 2.38B | 2.17B | 3.29B | 3.48B | 3.53B | EBIT |
-188.00M | -660.00M | -974.00M | 86.00M | 397.00M | 357.00M | EBITDA |
-353.75M | -713.00M | 348.00M | 1.35B | 1.28B | 1.21B | Net Income Common Stockholders |
-592.00M | -1.27B | -708.00M | 281.00M | 271.00M | 253.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.46B | 4.17B | 3.98B | 6.05B | 6.38B | 6.62B | Total Assets |
20.54B | 21.29B | 22.39B | 24.32B | 24.23B | 22.58B | Total Debt |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-3.46B | -4.17B | -3.98B | -6.05B | -6.38B | -6.62B | Total Liabilities |
4.86B | 5.50B | 5.50B | 6.05B | 5.71B | 4.85B | Stockholders Equity |
15.68B | 15.78B | 16.90B | 18.27B | 18.52B | 17.73B |
Cash Flow | Free Cash Flow | ||||
0.00 | -605.00M | -2.40B | -708.00M | -14.00M | 1.14B | Operating Cash Flow |
0.00 | 170.00M | -1.75B | -139.00M | 878.00M | 1.80B | Investing Cash Flow |
0.00 | 101.00M | -136.00M | -15.00M | -891.00M | -700.00M | Financing Cash Flow |
0.00 | -91.00M | -177.00M | -177.00M | -222.00M | -287.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥23.16T | 20.08 | 14.32% | 0.50% | -0.49% | 19.71% | |
78 Outperform | ¥5.14T | 28.76 | 8.97% | 0.70% | -1.55% | 17.24% | |
77 Outperform | $127.82B | 10.26 | 8.57% | 4.47% | 7.25% | -51.36% | |
68 Neutral | ¥15.44B | 9.16 | 4.27% | 5.48% | -23.11% | ||
62 Neutral | $11.72B | 10.43 | -7.10% | 2.91% | 7.41% | -7.94% | |
61 Neutral | ¥157.38B | 24.87 | 3.09% | 3.82% | -1.01% | -26.38% | |
50 Neutral | ¥11.27B | 834.82 | 1.57% | -1.06% | -111.31% |